Cargando…

Animal venoms: a novel source of anti-Toxoplasma gondii drug candidates

Toxoplasma gondii (T. gondii) is a nucleated intracellular parasitic protozoan with a broad host selectivity. It causes toxoplasmosis in immunocompromised or immunodeficient patients. The currently available treatments for toxoplasmosis have significant side effects as well as certain limitations, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Dongqian, Liu, Xiaohua, Li, Jing, Xie, Jing, Jiang, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188992/ https://www.ncbi.nlm.nih.gov/pubmed/37205912 http://dx.doi.org/10.3389/fphar.2023.1178070

Ejemplares similares

Anti-Toxoplasma gondii Effects of Lipopeptide Derivatives of Lycosin-I
por: Liu, Xiaohua, et al.
Publicado: (2023)

Anti-Toxoplasma gondii Effects of a Novel Spider Peptide XYP1 In Vitro and In Vivo
por: Liu, Yuan, et al.
Publicado: (2021)

Editorial: Venoms, Animal and Microbial Toxins
por: Cao, Zhijian, et al.
Publicado: (2021)

Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box
por: Spalenka, Jérémy, et al.
Publicado: (2018)

Editorial: Venoms, animal and microbial toxins, volume II
por: Cao, Zhijian, et al.
Publicado: (2022)

Drug Resistance in Toxoplasma gondii
por: Montazeri, Mahbobeh, et al.
Publicado: (2018)

From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery
por: Bordon, Karla de Castro Figueiredo, et al.
Publicado: (2020)

Toxoplasma gondii vaccine candidates: a concise review
por: Mamaghani, Amirreza Javadi, et al.
Publicado: (2022)

Promising Drug Targets and Compounds with Anti-Toxoplasma gondii Activity
por: da Silva, Marco, et al.
Publicado: (2021)

Inhibitory Effect of Hemiscorpius lepturus Scorpion Venom Fractions on Tachyzoites of Toxoplasma gondii
por: Khaleghi Rostamkolaie, Lida, et al.
Publicado: (2022)

Correction: Liu et al. Anti-Toxoplasma gondii Effects of a Novel Spider Peptide XYP1 In Vitro and In Vivo. Biomedicines 2021, 9, 934
por: Liu, Yuan, et al.
Publicado: (2022)

Detection of antibodies to Toxoplasma gondii in wild animals in Brazil
por: da Silva, Rodrigo Costa, et al.
Publicado: (2014)

The life-cycle of Toxoplasma gondii reviewed using animations
por: Attias, Márcia, et al.
Publicado: (2020)

Toxoplasma gondii Oocyst–specific Antibodies and Source of Infection
por: Muñoz-Zanzi, Claudia A., et al.
Publicado: (2010)

Toxoplasma gondii
por: Liesenfeld, Oliver
Publicado: (2009)

Investigation of Antiparasitic Activity of Two Marine Natural Products, Estradiol Benzoate, and Octyl Gallate, on Toxoplasma gondii In Vitro
por: Lu, Daiqiang, et al.
Publicado: (2022)

Pathogenicity of Five Strains of Toxoplasma gondii from Different Animals to Chickens
por: Wang, Shuai, et al.
Publicado: (2015)

The Apoptotic Role of Metacaspase in Toxoplasma gondii
por: Li, Muzi, et al.
Publicado: (2016)

Toxoplasma gondii in wild and domestic animals from New Caledonia
por: Roqueplo, C., et al.
Publicado: (2011)

Genetic characterization of Toxoplasma gondii in meat-producing animals in Iran
por: Amouei, Afsaneh, et al.
Publicado: (2022)

The transcriptome of Toxoplasma gondii
por: Radke, Jay R, et al.
Publicado: (2005)

Toxoplasma gondii and Schizophrenia
por: Torrey, E. Fuller, et al.
Publicado: (2003)

Toxoplasma gondii, Brazil
por: Gomez-Marin, Jorge
Publicado: (2007)

Prenatal Toxoplasma gondii
por: Linn, Edward S.
Publicado: (2011)

Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis
por: Zhao, Guanghui, et al.
Publicado: (2013)

Toxoplasma gondii Protein Disulfide Isomerase (TgPDI) Is a Novel Vaccine Candidate against Toxoplasmosis
por: Wang, Hai-Long, et al.
Publicado: (2013)

Effects of different drugs and hormone treatment on Toxoplasma gondii glutathione S-transferase 2
por: Li, Shuang, et al.
Publicado: (2022)

Spatial serosurvey of anti-Toxoplasma gondii antibodies in individuals with animal hoarding disorder and their dogs in Southern Brazil
por: da Cunha, Graziela Ribeiro, et al.
Publicado: (2020)

A meta-analysis of the prevalence of Toxoplasma gondii in animals and humans in Ethiopia
por: Gebremedhin, Endrias Zewdu, et al.
Publicado: (2015)

Toxoplasma gondii Recombinant Antigens in the Serodiagnosis of Toxoplasmosis in Domestic and Farm Animals
por: Ferra, Bartłomiej, et al.
Publicado: (2020)

Toxoplasma gondii contamination at an animal agriculture facility: Environmental, agricultural animal, and wildlife contamination indicator evaluation
por: Kurth, Katherine, et al.
Publicado: (2021)

Editorial: Medicinal plants as a source of novel autoimmune-modulating and anti-inflammatory drug products
por: Wang, Yang, et al.
Publicado: (2022)

Toxoplasma gondii Pneumonia in an Immunocompetent Individual
por: Shen, Chang-xing, et al.
Publicado: (2015)

Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
por: Duan, Linshan, et al.
Publicado: (2021)

Evaluation of Anti-Toxoplasma gondii Effect of Ursolic Acid as a Novel Toxoplasmosis Inhibitor
por: Choi, Won Hyung, et al.
Publicado: (2018)

Synthesis and In Vitro Anti-Toxoplasma gondii Activity of Novel Thiazolidin-4-one Derivatives
por: Trotsko, Nazar, et al.
Publicado: (2019)

Serologic Detection of Anti Toxoplasma gondii Infection in Diabetic Patients
por: Shirbazou, Shahnaz, et al.
Publicado: (2013)

Seroprevalence of anti-Toxoplasma gondii antibodies in Egyptian sheep and goats
por: Al-Kappany, Yara M., et al.
Publicado: (2018)

In vitro anti-Toxoplasma gondii efficacy of synthesised benzyltriazole derivatives
por: Guo, Huanping, et al.
Publicado: (2021)

Evaluation of the anti-Toxoplasma gondii Activity of Hederagenin in vitro and in vivo
por: Zhang, Run-Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sqolhake8bv74602a2bjtu5rh6